Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Multiple acquisitions for Provident Bankshares Corporation
Represented Provident Bankshares Corporation in multiple acquisitions and dispositions, including its $330 million acquisition of Southern Financial more
First lien and second lien credit facilities of a paper manufacturing company
Represented a lead agent and lead arranger in connection with $95 million syndicated secured first lien and second lien credit facilities used to more
Strategic patent counseling services to Red Hat Inc.
Provides strategic patent counseling services to Red Hat Inc., the most recognized open-source software company in the world. Analyzes and more
Acquisition of General Electric's Hydro Equipment Business
Represented Andritz AG in the acquisition of the hydro power equipment business of General Electric, including GE’s majority interest in GE Hydro more